Literature DB >> 50385

Complement activation in bullous skin diseases.

R E Jordon.   

Abstract

Pemphigus, bullous pemphigoid, cicatricial pemphigoid, dermatitis herpetiformis, and herpes gestationis are members of the chronic vesiculobullous skin diseases of man. The complement system, including both the classical and alternative pathways, may be important in the pathogenesis of these diseases. In pemphigus, early complement components (C1, C4, and C2) appear to be activated in addition to later components (C3 and C5), suggestive of classical pathway activation. Participation of properdin in addition to early complement components suggests local activation of both complement pathways in bullous pemphigoid and cicatricial pemphigoid. Herpes gestationis and dermatitis herpetiformis may be bullous skin diseases entirely mediated by the alternate or properdin pathway. The specific immunopathologic findings in these diseases are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50385     DOI: 10.1111/1523-1747.ep12598113

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

Review 1.  Complement and cutaneous autoimmune blistering diseases.

Authors:  Elizabeth Lessey; Ning Li; Luis Diaz; Zhi Liu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Authors:  Griet A Van Roey; Christopher C Vanison; Jeffanie Wu; Julia H Huang; Lydia A Suh; Roderick G Carter; James E Norton; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Whitney W Stevens; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-12-12       Impact factor: 10.793

3.  The location of tick salivary antigens, complement and immunoglobulin in the skin of guinea-pigs infested with Dermacentor andersoni larvae.

Authors:  J R Allen; H M Khalil; J E Graham
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

4.  Herpes gestationis. Immunopathology and characterization of the HG factor.

Authors:  S I Katz; K C Hertz; H Yaoita
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

5.  Role of different pathways of the complement cascade in experimental bullous pemphigoid.

Authors:  Kelly C Nelson; Minglang Zhao; Pamela R Schroeder; Ning Li; Rick A Wetsel; Luis A Diaz; Zhi Liu
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

6.  The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid.

Authors:  Lisa Heimbach; Zhuowei Li; Paula Berkowitz; Minglang Zhao; Ning Li; David S Rubenstein; Luis A Diaz; Zhi Liu
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

7.  The role of complement in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; S J Swartz; J A Fairley; G O Till; J L Troy; L A Diaz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

9.  Production of anti-basement membrane-zone antibody by peripheral blood leukocytes of pemphigoid patients.

Authors:  A R Ahmed; R H Stevens; A Saxon
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

10.  Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients.

Authors:  Roxana M Chiorean; Adrian Baican; Mayson B Mustafa; Annette Lischka; Daniel-Corneliu Leucuta; Vasile Feldrihan; Michael Hertl; Cassian Sitaru
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.